UBC biotech spin-off developing next-generation radiopharmaceuticals to improve cancer treatment
March 14, 2023
With roots in UBC research, learn more about how three researchers are developing radiopharmaceuticals to improve cancer treatment.
Based on more than a decade of ground-breaking research at UBC and BC Cancer, the cancer drugs act like a homing device — seeking out tumours to deliver targeted radiation treatment, while having minimal impact on nearby healthy tissues. This precision targeting results in drugs that can be more effective and have fewer side effects for patients than traditional radiation treatments.
- Research
- Feature story